Correction: Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595186/
https://www.ncbi.nlm.nih.gov/pubmed/28948029
http://dx.doi.org/10.1136/bmjdrc-2017-000391corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595186/
https://www.ncbi.nlm.nih.gov/pubmed/28948029
http://dx.doi.org/10.1136/bmjdrc-2017-000391corr1

Ejemplares similares